Photochemically-enabled, post-translational production of C-terminal amides
Open Access
- 30 November 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-8
Abstract
C-terminal α-amidated peptides are attractive therapeutic targets, but preparative methods to access amidated pharmaceuticals are limited both on lab and manufacturing-scale. Here we report a straightforward and scalable approach to the C-terminal α-amidation of peptides and proteins from cysteine-extended polypeptide precursors. This amidation protocol consists of three highly efficient steps: 1) selective cysteine thiol substitution with a photolabel, 2) photoinduced decarboxylative elimination and 3) enamide cleavage by simple acidolysis or inverse electron demand Diels-Alder reaction. We provide a blueprint for applying this protocol to the semi-recombinant production of therapeutically relevant targets where gram scale C-terminal α-amidation is achieved in a photoflow reactor on a recombinantly prepared peptide YY analogue and a GLP-1/amylin co-agonist precursor peptide. Robust performance of this reaction cascade in flow highlights the potential of this chemistry to enable amidated drug leads to enter development that would not be viable on commercial scale using existing technology.Keywords
This publication has 45 references indexed in Scilit:
- ExenatideNature Reviews Drug Discovery, 2005
- Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activityProceedings of the National Academy of Sciences, 2003
- Large-scale manufacture of peptide therapeutics by chemical synthesisNature Reviews Drug Discovery, 2003
- Gut hormone PYY3-36 physiologically inhibits food intakeNature, 2002
- A role for glucagon-like peptide-1 in the central regulation of feedingNature, 1996
- Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.Journal of Clinical Investigation, 1993
- C-terminal amidation of calcitonin by carboxypeptidase Y catalyzed transpeptidation with a photocleavable nucleophile.1992
- Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus.Proceedings of the National Academy of Sciences, 1989
- Synthesis and hypertensive activity of neuropeptide Y fragments and analogs with modified N- or C-termini or D-substitutionsJournal of Medicinal Chemistry, 1989
- Peptide α-AmidationAnnual Review of Physiology, 1988